Come up with a name for your new list and we'll add to it:
Anza Therapeutics raised a round of funding on , . Investors include
Kleiner Perkins Caufield & Byers.
Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabo…